Paragonix Technologies

Paragonix Technologies is a commercial-stage medical device company that has established a new standard of care in organ transplantation through its integrated preservation and logistics platform. Founded in 2010 and headquartered in Cambridge, Massachusetts, the company offers a suite of organ-specific transport devices that provide precise temperature control to mitigate cold ischemic injury, supported by a HIPAA-compliant digital app for case management. With over 10,000 donor organs preserved and support for more than 180 transplant centers globally, Paragonix leverages its large-scale GUARDIAN registries to generate real-world evidence, aiming to improve transplant outcomes and expand the viable donor pool. The company operates a business model combining device sales with digital services and clinical support.

Integrated organ preservation platform combining single-use, organ-specific transport devices that maintain controlled hypothermic temperatures with a digital HIPAA-compliant app for real-time GPS tracking, temperature monitoring, and case logistics management.

Paragonix competes primarily against the entrenched standard of static cold storage on ice. It also faces competition from other medical device companies offering hypothermic preservation systems (e.g., TransMedics for portable normothermic perfusion, though a different technological approach). The long-term competitive threat includes broader adoption of more complex and expensive ex-vivo normothermic perfusion platforms that maintain organs in a near-physiological state.